๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Alemtuzumab is an antibody that reduces the strength of the immune system t...
Status
Recruiting
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-11
Trial ID
NCT05501756
Treatments Being Tested
Dyskeratosis congenita is a disease that affects numerous parts of the body...
Status
Active Not Recruiting
Location
University of Chicago
Start Date
2012-07
Trial ID
NCT01659606
Treatments Being Tested
This is a standard of care treatment guideline for allogeneic hematopoetic ...
Status
Active Not Recruiting
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-09-04
Trial ID
NCT01652092
The purpose of this study is to determine the safety and toxicity and feasi...
Status
Terminated
Location
Columbia Presbyterian Medical Center
Start Date
2007-09-06
Trial ID
NCT00801931
The goal of this clinical research study is to compare the effect of adding...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-09-23
Trial ID
NCT02385110
Treatments Being Tested
This is a phase II trial of T cell receptor alpha/beta depletion (ฮฑ/ฮฒ TCD) ...
Status
Recruiting
Location
Masonic Cancer Center at University of Minnesota
Start Date
2018-11-13
Trial ID
NCT03579875
This study tests the clinical outcomes of one of two preparative regimens (...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2002-06
Trial ID
NCT00176852
RATIONALE: Giving a monoclonal antibody, such as alemtuzumab, and chemother...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2007-01
Trial ID
NCT00618540
Treatments Being Tested
This study tests the clinical outcomes of a preparative regimen of fludarab...
Status
Completed
Location
Masonic Cancer Center University of Minnesota
Start Date
2002-08
Trial ID
NCT00176865
Fludarabine-based preparative regimen followed by an allogeneic hematopoiet...
Status
Completed
Location
University of Minnesota Medical Center, Fairview
Start Date
2015-01-10
Trial ID
NCT02162420